CA-DCP/PIXAR
Disney Consumer Products today unveiled exclusive details about the new global toy lines celebrating Disney∙Pixar’s Inside Out and The Good Dinosaur , debuting theatrically in the U.S. on June 19, 2015, and Nov. 25, 2015, respectively. Both movies will have robust toy lines from best-in-class licensee TOMY, whose innovative approach, strength in international markets and ability to reflect Pixar’s unique storytelling in its product lines made them the ideal choice for Pixar Animation Studios’ most exciting year yet.
"We put our hearts into these films, so it's incredibly important to us that our toy-making partners care about and do justice to these characters we know so well," said John Lasseter, Chief Creative Officer, Walt Disney and Pixar Animation Studios. "When I visited TOMY's headquarters in Japan, I was impressed by their commitment to quality and craftsmanship. The toys they've created for Inside Out and The Good Dinosaur are fantastic—they've truly brought our characters to life.”
TOMY’s toy line for Inside Out is inspired by the humor, visual style and whimsical elements within the film. The poseable character figures have light up features and all of the toys allow for self-expression and re-creation of key movie moments. The broad toy range for The Good Dinosaur appeals to kids of all ages, for both action figure play and more sophisticated remote control walking and talking. The unique characteristics of the film’s dinosaurs, such as how they move and run, are reflected in the toy line, and several working models were built and shared with filmmakers to get the movements just right. Additionally, RFID technology allows the characters to interact as they do in the film, bringing their unique personalities and stories to life.
“With the debut of Cars in 2006, we introduced personality and humor to toy vehicles adding a new dimension of storytelling to an established play pattern, and lifting the entire category at retail. Dinosaurs have always fascinated kids and we believe Pixar’s unique take on our prehistoric friends will have a similar impact on the way they play with them in the future,” said Josh Silverman, executive vice president global licensing, Disney Consumer Products.
Pixar films have a strong track record of success at the box office and at retail. 20 years after the theatrical release of Toy Story in 1995, a film that transformed the animation industry and jumpstarted a billion dollar toy franchise, Pixar stories and characters hold a unique place in audiences’ hearts and kids’ toy boxes. Toy Story 3 holds the title of the second biggest animated film of all time reaching more than $1 billion in global box office sales. The iconic 12 inch Buzz Lightyear action figures have sold in excess of 10 million units globally over the past decade.
This summer Disney Consumer Products will roll out a special toy line to celebrate Toy Story’s 20th anniversary that will include a broad assortment of characters in a collectible figure range, favorite characters in action figure form and true-to-film talking versions of Buzz, Woody and Jessie.
About Inside Out
From an adventurous balloon ride above the clouds to a monster-filled metropolis, Academy Award®-winning director Pete Docter (Monsters, Inc. , Up ) has taken audiences to unique and imaginative places. In Disney∙Pixar’s original movie Inside Out , he will take us to the most extraordinary location of all—inside the mind.
Growing up can be a bumpy road, and it's no exception for Riley, who is uprooted from her Midwest life when her father starts a new job in San Francisco. Like all of us, Riley is guided by her emotions – Joy (Amy Poehler), Fear (Bill Hader), Anger (Lewis Black), Disgust (Mindy Kaling) and Sadness (Phyllis Smith). The emotions live in Headquarters, the control center inside Riley’s mind, where they help advise her through everyday life. As Riley and her emotions struggle to adjust to a new life in San Francisco, turmoil ensues in Headquarters. Although Joy, Riley's main and most important emotion, tries to keep things positive, the emotions conflict on how best to navigate a new city, house and school.
About The Good Dinosaur
The Good Dinosaur asks the generations-old question: What if the asteroid that forever changed life on Earth missed the planet completely and giant dinosaurs never became extinct? In theaters November 25, 2015, the film is a humorous and exciting original story about Arlo, a lively Apatosaurus with a big heart. After a traumatic event unsettles Arlo’s family, he sets out on a remarkable journey, gaining an unlikely companion along the way—a human boy. The Good Dinosaur is an extraordinary journey of self-discovery full of thrilling adventure, hilarious characters and poignant heart.
About Disney Consumer Products
Disney Consumer Products (DCP) is the business segment of The Walt Disney Company (NYSE:DIS) that delivers innovative and engaging product experiences across thousands of categories from toys and apparel to books and fine art. As the world's largest licensor, DCP inspires the imaginations of people around the world by bringing the magic of Disney into consumers' homes with products they can enjoy year-round. DCP is comprised of three business units: Licensing, Publishing and Disney Store. The Licensing business is aligned around five strategic brand priorities: Disney Media, Classics & Entertainment , Disney & Pixar Animation Studios , Disney Princess & Disney Fairies , Lucasfilm and Marvel . Disney Publishing Worldwide (DPW) is the world's largest publisher of children's books, magazines, and digital products and also includes an English language learning business, consisting of Disney English learning centers across China and a supplemental learning book program. DPW's growing library of digital products includes best-selling eBook titles and original apps that leverage Disney content in innovative ways. The Disney Store retail chain operates across North America, Europe and Japan with more than 350 stores worldwide and is known for providing consumers with high-quality, unique products. Disney's official shopping portals online are www.DisneyStore.com and www.DisneyStore.co.uk . For more information, please visit Disney Consumer Products www.DisneyConsumerProducts.com or follow us at www.YouTube.com/DisneyLiving , www.Facebook.com/DisneyLiving , www.Twitter.com/DisneyLiving and www.Pinterest.com/DisneyLiving andwww.Instagram.com/DisneyLiving .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150113005285/en/
Contact:
Disney Consumer Products
Joss Hastings, 818-544-0382
joss.hastings@disney.com
or
Liz
Virji, 818-544-1926
liz.virji@disney.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum